Body Awareness Therapy and Biomarkers in Fibromyalgia
Recruiting · NCT05555394 · Interventional (participants receive a specific treatment) · Lead sponsor: Universitat de Lleida
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
A randomized trial of Basic Body Awareness Therapy (BBAT) is applied in fibromyalgia patients as compared with a control intervention consisting of stretching. Sessions of BBAT lasted 90 min each and took place twice a week form 12 weeks. The primary end point is a change in the biomarkers and neurotransmitters and the Fibromyalgia Impact Questionnaire and the secondary end points include Visual Analog Scale, State Trait Anxiety inventory, Beck Depression Inventory. All assessments will be repeated at post treatment, 12 and 24 weeks and 1 year follow-up.
Who can take part
Inclusion criteria
- whose diagnosed of fibromyalgia almost 6 months before
- whose could be in different position such as lying, sitting, and stand-up
Exclusion criteria
- whose are diagnosed of disease that it worse the pain
- pregnancy
- whose are diagnosed of other disease such as rheumatology, neurology, cardiac problems o another internal medical condition,malignant disease or acute infections
Where it is running
2 locations listed.
- Consorci Sanitari de l'Anoia - Igualada, Barcelona, Spain
- Cristina Bravo Navarro - Igualada, Barcelona, Spain